Friday, February 10, 2012 Issue 2   VOLUME 1 ISSUE 2   TOPICS Parkinson's disease CONTENTS New Drug for the Treatment of Advanced Parkinson's Disease Rasagiline May Slow the Progression of Early Parkinson's Disease You Are Not Alone. Glossary Randomized Delayed-Start Design Hoehn and Yahr Scale ARCHIVE Issue 1 April 7, 2004 Vol. 1 Issue 1 SEARCH Search for articles containing: SUBSCRIBE Subscribe to WE MOVE News New Drug for the Treatment of Advanced Parkinson's Disease The FDA announced on April 21, 2004 that it has approved Apokyn (apomorphine hydrochloride injectable) for the treatment of off episodes in patients with advanced Parkinson's disease. [FULL STORY]   Rasagiline May Slow the Progression of Early Parkinson's Disease Patients who took 2 mg of rasagiline mesylate per day for 12 months had fewer motor symptoms and an increased ability to perform activities of daily living compared to patients who took the medication for only six months. [FULL STORY]   You Are Not Alone. WE MOVE offers discussion forums on a variety of topics related to movement disorders. [FULL STORY]   Glossary Definitions of terms with which you might not be familiar are included in the glossary for your ease in reading WE MOVE News. [FULL STORY]     Supported by an educational grant from the Medtronic Foundation Published by WE MOVE Copyright © 2004 WE MOVE. All rights reserved. TELL A FRIEND   Judith Blazer, Executive Director, WE MOVE   Meghan Murphy, CME and Communications Coordinator   Edited by Richard Robinson, Cate Murray and Joy Leffler

Powered by IMN™